Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-12

Clinical Trial Update: A Study to Evaluate the Effects of the Neuroflo Device in People Who Have Had a Stroke [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the Neuroflo device for acute stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NeuroFlo

Snippet

Sponsor: University of California, Los Angeles | Conditions: Acute Stroke | Phase 1 | Status: WITHDRAWN